Walgreen Co. v. Anest CA3

CourtCalifornia Court of Appeal
DecidedJuly 24, 2023
DocketC097574
StatusUnpublished

This text of Walgreen Co. v. Anest CA3 (Walgreen Co. v. Anest CA3) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Walgreen Co. v. Anest CA3, (Cal. Ct. App. 2023).

Opinion

Filed 7/24/23 Walgreen Co. v. Anest CA3 NOT TO BE PUBLISHED California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA THIRD APPELLATE DISTRICT (Butte) ----

WALGREEN CO., C097574

Plaintiff and Respondent, (Super. Ct. No. 21CV00269)

v.

CHRISTINA P. ANEST,

Defendant and Appellant.

Defendant and appellant Christina P. Anest was employed by plaintiff and respondent Walgreen Co. (Walgreens).1 When she was hired, she signed an agreement pursuant to which Walgreens would immediately pay her a $35,000 incentive payment, but if she failed to remain continuously employed for three full years, she had to repay the entire amount. Anest left Walgreens before completing three years of employment,

1 Plaintiff and respondent is identified as “Walgreen Co.” in the papers and as “Walgreens” in the agreement that lies at the heart of this case. We refer to it as Walgreens throughout.

1 and when she failed to repay the incentive payment, Walgreens sued her for breach of contract. Walgreens then moved for summary judgment and the trial court granted the motion and entered judgment against Anest. Anest appeals and we affirm. BACKGROUND Anest was hired by Walgreens in May 2016 as a pharmacist. When she was hired, she was offered a $30,000 sign-on bonus incentive payment and a $5,000 relocation incentive payment (she lived in Los Angeles at the time and relocated to the Chico/Redding area for the position), subject to the following terms and conditions:

“1. To avoid any repayment obligation with respect to the incentive payment, Pharmacist must remain continuously employed by Walgreens . . . for a period of 3 full year(s) of actual service (the ‘required employment period’). . . .

“2. If Pharmacist leaves Walgreens (for any reason) before completely fulfilling the required employment period, then Pharmacist must repay Walgreens the entire incentive payment amount (‘repayment obligation’). Partial completion of the required employment period will not reduce Pharmacist’s repayment obligation. . . .

“3. By accepting the incentive payment Pharmacist authorizes Walgreens to satisfy Pharmacist’s repayment obligation with any amounts owed by Walgreens to Pharmacist . . . . Any remaining repayment obligation balance must be repaid in full within thirty (30) calendar days after request by Walgreens. If not timely repaid, then the entire unpaid balance shall be increased by a penalty of 8% per year . . . . [¶] . . . [¶]

“5. This Agreement is not a contract or guarantee of employment for a definite period. As always, either Pharmacist or Walgreens may terminate the employment relationship for any reason, at any time, with or without cause or notice (i.e., ‘at-will’).” In June 2016, Anest accepted the offer by electronically signing the agreement and checking a box attesting she “accepts and agrees to all of the terms and conditions set

2 forth in this Incentive Payment Agreement,”2 and Walgreens paid her the incentive payment, with payroll taxes deducted. Anest was terminated in February 2018 (we are not told why), after 21 months of employment, which triggered her obligation to repay the incentive payment. In March 2018, Walgreens sent her an invoice for $32,322.50 ($35,000 less $2,677.50 for FICA payments that Walgreens was obligated to pay). When Anest failed to pay the invoice in full, Walgreens filed a complaint against her for breach of contract and a common count (money had and received), and it ultimately filed a motion for summary judgment. At the time the summary judgment motion was filed, Anest had made some payments, and Walgreens asserted she still owed it $27,890.51 pursuant to the terms of the agreement. In opposition to the motion, Anest, who represented herself, argued: the agreement was void and unenforceable because Walgreens had effectively altered its terms by characterizing the incentive payment as a loan in its motion papers; she did not breach the agreement; Walgreens breached the agreement by terminating her; requiring her to repay the incentive payment would be tantamount to an employer collecting wages previously paid, in violation of Labor Code section 221; and Walgreens could not substantiate the amount it claimed she owed. The trial court granted the motion, finding the following facts were undisputed and established Walgreens was entitled to judgment: (1) Walgreens hired Anest in May 2016, and her employment was terminated in February 2018; (2) in connection with her employment, Walgreens offered Anest $35,000 in incentive payments subject to the terms and conditions quoted above, and she accepted the offer; (3) a month after she was

2 There were actually two separate agreements—one for the sign-on bonus incentive payment and one for the relocation incentive payment. The terms of both agreements were identical. The parties do not discuss the agreements separately, and we thus frequently refer to the “agreement” in the singular and to a single $35,000 incentive payment.

3 terminated, Walgreens sent her an invoice for the full amount owed; and (4) taking into account amounts she had already repaid, she still owed $27,890.51. On December 1, 2022, judgment was entered in favor of Walgreens against Anest in the sum of $27,890.51. This appeal followed. DISCUSSION This case comes to us after the trial court granted Walgreens’ motion for summary judgment. “We review a grant of summary judgment de novo; we must decide independently whether the facts not subject to triable dispute warrant judgment for the moving party as a matter of law.” (Intel Corp. v. Hamidi (2003) 30 Cal.4th 1342, 1348.) “We need not defer to the trial court and are not bound by the reasons in its summary judgment ruling; we review the ruling of the trial court, not its rationale.” (Oakland Raiders v. National Football League (2005) 131 Cal.App.4th 621, 630.) Thus, “We may affirm the summary judgment on any correct legal theory, as long as the parties had an adequate opportunity to address the theory in the trial court.” (Drake v. Pinkham (2013) 217 Cal.App.4th 400, 406.) Although our review is de novo, that does not mean we ignore the trial court’s decision. Instead, that decision is presumed correct, and the appellant has the burden of affirmatively establishing reversible error. (Swigart v. Bruno (2017) 13 Cal.App.5th 529, 535.) We begin by noting that Anest is representing herself. A self-represented party, however, “is to be treated like any other party and is entitled to the same, but no greater consideration than other litigants and attorneys.” (Barton v. New United Motor Manufacturing, Inc. (1996) 43 Cal.App.4th 1200, 1210.) That means Anest is subject to all applicable rules of appellate procedure and briefing, including the rule that judgments and orders are presumed correct, and it is the appellant’s job to affirmatively demonstrate error. (Denham v. Superior Court (1970) 2 Cal.3d 557, 564.) “To demonstrate error, appellant must present meaningful legal analysis supported by citations to authority and citations to facts in the record that support the claim of error.” (In re S.C. (2006)

4 138 Cal.App.4th 396, 408.) “[A]n appellant is required to not only cite to valid legal authority, but also explain how it applies in his case.” (Hodjat v. State Farm Mutual Automobile Ins. Co. (2012) 211 Cal.App.4th 1, 10.) “ ‘[O]ne cannot simply say the court erred, and leave it up to the appellate court to figure out why.’ ” (People v. JTH Tax, Inc.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Drake v. Pinkham CA3
217 Cal. App. 4th 400 (California Court of Appeal, 2013)
Christina C. v. County of Orange CA4/3
220 Cal. App. 4th 1371 (California Court of Appeal, 2013)
Denham v. Superior Court
468 P.2d 193 (California Supreme Court, 1970)
Atchley v. City of Fresno
151 Cal. App. 3d 635 (California Court of Appeal, 1984)
Lucian v. All States Trucking Co.
116 Cal. App. 3d 972 (California Court of Appeal, 1981)
Hye Young Yoo v. Sue Jho
55 Cal. Rptr. 3d 243 (California Court of Appeal, 2007)
Barton v. New United Motor Manufacturing, Inc.
43 Cal. App. 4th 1200 (California Court of Appeal, 1996)
Neisendorf v. Levi Strauss & Co.
49 Cal. Rptr. 3d 216 (California Court of Appeal, 2006)
Kelecheva v. Multivision Cable T v. Corp.
18 Cal. App. 4th 521 (California Court of Appeal, 1993)
In Re SC
41 Cal. Rptr. 3d 453 (California Court of Appeal, 2006)
Steinhebel v. Los Angeles Times Communications
24 Cal. Rptr. 3d 351 (California Court of Appeal, 2005)
L. Byron Culver & Associates v. Jaoudi Industrial & Trading Corp.
1 Cal. App. 4th 300 (California Court of Appeal, 1991)
Oakland Raiders v. National Football League
32 Cal. Rptr. 3d 266 (California Court of Appeal, 2005)
Koehl v. Verio, Inc.
48 Cal. Rptr. 3d 749 (California Court of Appeal, 2006)
Intel Corp. v. Hamidi
71 P.3d 296 (California Supreme Court, 2003)
Guz v. Bechtel National, Inc.
8 P.3d 1089 (California Supreme Court, 2000)
Schachter v. Citigroup, Inc.
218 P.3d 262 (California Supreme Court, 2009)
Hodjat v. State Farm Mutual Automobile Insurance
211 Cal. App. 4th 1 (California Court of Appeal, 2012)
City of Santa Maria v. Adam
211 Cal. App. 4th 266 (California Court of Appeal, 2012)
People v. JTH Tax, Inc.
212 Cal. App. 4th 1219 (California Court of Appeal, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Walgreen Co. v. Anest CA3, Counsel Stack Legal Research, https://law.counselstack.com/opinion/walgreen-co-v-anest-ca3-calctapp-2023.